National EC in Pakistan Rejects Placebo-based RCTs for COVID-19 Vaccines—Major Academic Research Centers Respond by Modifying Protocols

National EC in Pakistan Rejects Placebo-based RCTs for COVID-19 Vaccines--Major Academic Research Centers Respond by Modifying Protocols

In an interesting move, the nation of Pakistan via its National Bioethics Committee of Pakistan (NBC) rejected further need for randomized, placebo-controlled studies when it comes to the next batch of major clinical trials, such as mRNA-based COVID-19 vaccine experiments. The National Ethic’s Committee (EC) centers the rejection based on the fact that a number of vaccines are now in use in Pakistan. Thus, they posit that making more of their citizens sign up for possibly receiving a placebo in a study, essentially serving as “guinea pigs” isn’t acceptable anymore. Consequently, the world’s fifth most populated nation of about 240 million people has rejected major China and European-based pharmaceutical industry-sponsored clinical trials on these ethically-based grounds. The major trial sites, such as Aga Khan University Hospital (AKUH) and University of Health Sciences (UHS) are apparently willing to modify the proposed study protocols.

As reported recently in Geo News, an official from the national government shared that this nation would procure an mRNA-based vaccine “very soon.”

Academic Medical Centers Told No

Apparently, the NBC official reported that principal inve...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee